Second-look TURBT showed limited value in altering outcomes for high-grade Ta bladder cancer after complete resection.

TURBT, or transurethral resection of bladder tumor, is a common, minimally invasive outpatient procedure used to diagnose, stage, and treat bladder cancer.

TURBT was associated with persistent sexual dysfunction in men, pointing to the importance of incorporating sexual health into postoperative evaluation.

Depending on the disease risk, TURBT on its own can offer similar protection from disease recurrence. Not having a comparator makes it difficult to know if there's really any value-add over TURBT.

Re-TURBT was performed in 10% of patients receiving neoadjuvant mitomycin C and in 19% of those in the control group. Within the neoadjuvant mitomycin C group, results of pre-mitomycin C biopsies ...

TURBT is the current standard of care (SOC) for patients with low-grade, intermediate-risk NMIBC; however, the study authors noted that this treatment method provides inadequate disease control and ...

This approach to initial staging made it possible for about 17% of patients to safely skip TURBT, said Nicholas D. James, PhD, of the Institute of Cancer Research in London, and colleagues.

TURBT is the main treatment for non muscle invasive bladder cancer. You usually have this operation as your first treatment. TURBT can also diagnose bladder cancer and find out whether the cancer has ...

ATLAS is a global, open-label, randomized controlled Phase 3 trial designed to assess the efficacy and safety of UGN-102, with or without TURBT, vs. TURBT alone in patients diagnosed with LG-IR-NMIBC.

Photodynamic diagnosis-guided TURBT did not reduce 3-year recurrence rates of non–muscle-invasive bladder cancer in a real-world trial compared with white light-guided cystoscopy.